Jemal A, Bray F, Center MM, Ferlay J: Elizabeth Ward; David Forman. Global Cancer Statistics. CA CANCER J CLIN. 2011, 61: 69-90. 10.3322/caac.20107.
Article
PubMed
Google Scholar
Rutegård M, Lagergren P, Nordenstedt H, Lagergren J: Oesophageal adenocarcinoma: the new epidemic in men. 2011, 69 (3): 244-248. Epub 2011 May 23
Google Scholar
Tramacere I, La Vecchia C, Negri E: Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology. 2011 May, 22 (3): 344-349. 10.1097/EDE.0b013e31821092cd.
Article
PubMed
Google Scholar
Islami F, Fedirko V, Tramacere I, Bagnardi V, Jenab M, Scotti L, Rota M, Corrao G, Garavello W, Schüz J, Straif K, Negri E, Boffetta P, La Vecchia C: Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer. 2011 Nov 15, 129 (10): 2473-84. 10.1002/ijc.25885.
Article
PubMed
CAS
Google Scholar
Ahsan H, Neugut AI: Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Int Med. 1998, 128: 114-117.
Article
PubMed
CAS
Google Scholar
Levi F, Randimbison L, Te V-C, La Vecchia C: Increased risk of esophageal cancer after breast cancer. Annals of Oncology. 2005, 16: 1829-1831. 10.1093/annonc/mdi363.
Article
PubMed
CAS
Google Scholar
Curtis RE, Boice JD, Stovall M, et al: Leukemia risk following radiotherapy for breast cancer. J Clin Oncol. 1989, 7: 21-29.
PubMed
CAS
Google Scholar
Linda Morris B, Chen BE, Pfeiffer RM: Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat. 2007, 106: 439-451. 10.1007/s10549-007-9509-8.
Article
Google Scholar
Houston Thompson R: Bradley C. Leibovich, John C. Cheville, W. Scott Webster, Christine M. Lohse, Eugene D. Kwon, Horst Zincke* and Michael L. Blute. Second Primary Malignancies Associated With Renal Cell Carcinoma Histological Subtypes. The journal of urology. September 2006, 176: 900-904. 10.1016/j.juro.2006.04.080.
Article
PubMed
Google Scholar
Hao L: Kari Hemminki and Jan Sundquist. Renal Cell Carcinoma as First and Second Primary Cancer: Etiological Clues From the Swedish Family-Cancer Database. The Journal Of Urology. 2011, 185: 2045-2049. 10.1016/j.juro.2011.02.001.
Article
Google Scholar
Travis LB, Rabkin CS: Linda Morris Brown, James M. Allan and al. Cancer Survivorship Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations. J Natl Cancer Inst. 2006, 98: 15-25. 10.1093/jnci/djj001.
Article
PubMed
Google Scholar
Travis LB: The Epidemiology of Second Primary Cancers. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2020-2026. 10.1158/1055-9965.EPI-06-0414.
Article
PubMed
Google Scholar
Warren S, Gates O: Radiation-induced experimental cancer of the esophagus. Am] PathoI. 1968, 53: 667-679.
Google Scholar
Pierce DA, Shimizu Y, Preston DL, et al: Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950–1990. Radiat Res. 1996, 146: 1-27. 10.2307/3579391.
Article
PubMed
CAS
Google Scholar
Slaughter DP, Southwick HW: Mucosal carcinomas as a result of irradiation. Arch Surg. 1957, 74: 420-429. 10.1001/archsurg.1957.01280090118015.
Article
CAS
Google Scholar
Oliver M, Ulrich S, Marco Glashorster F-J: Prott and Normann Willich. Radiation-Induced Esophageal Carcinoma 30 Years after Mediastinal Irradiation: Case Report and Review of the Literature. Jpn J Clin OncoI. 1999, 29 (3): 164-170. 10.1093/jjco/29.3.164.
Article
Google Scholar
Zablotska LB, Chak A, Das A, Neugut AI: Increased Risk of Squamous Cell Esophageal Cancer after Adjuvant Radiation Therapy for Primary Breast Cancer. American Journal of Epidemiology. 2005, 161: 330-337. 10.1093/aje/kwi050.
Article
PubMed
Google Scholar
Michael Schaapveld, Otto Visser, Marieke J. Louwman, Elisabeth G.E. de Vries, Pax H.B, Willemse, Rene´e Otter, Winette T.A. van der Graaf, Jan-Willem W. Coebergh, and Flora E. van Leeuwen: A Dutch Population-Based Study. J Clin Oncol. 26: 1239-1246.
Chudecki B: Radiation cancer of the thoracic oesophagus. Br] Radiol. 1972, 45: 303-304. 10.1259/0007-1285-45-532-303.
Article
CAS
Google Scholar
Hisada M, Garber JE, Fung CY, Fraumeni JF, Li FP: Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998, 90: 606-611. 10.1093/jnci/90.8.606.
Article
PubMed
CAS
Google Scholar
Kalow W, Ozdemir V, Tang BK, Tothfalusi L, Endrenyi L: The science of pharmacological variability: an essay. Clin Pharmacol Ther. 1999, 66: 445-447. 10.1016/S0009-9236(99)70006-8.
Article
PubMed
CAS
Google Scholar
Evans WE, Relling MV: Moving towards individualized medicine with pharmacogenomics. Nature. 2004, 429: 464-468. 10.1038/nature02626.
Article
PubMed
CAS
Google Scholar
Felix CA: Chemotherapy-related second cancers. Multiple primary cancers. Edited by: Neugut AI, Meadows AT, Robinson E. 1999, Lippincott Williams & Wilkins, Philadelphia (PA), 137-164.
Google Scholar
Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA, et al: High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet. 1999, 354: 34-39. 10.1016/S0140-6736(98)11079-6.
Article
PubMed
CAS
Google Scholar
Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, et al: Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004, 104: 3872-3877. 10.1182/blood-2004-06-2161.
Article
PubMed
CAS
Google Scholar
Morgan WF, Day JP, Kaplan MI, McGhee EM, Limoli CL: Genomic instability induced by ionizing radiation. Radiat Res. 1996, 146: 247-258. 10.2307/3579454.
Article
PubMed
CAS
Google Scholar
farhang rabbani, victor e. reuter, jared katz, and paul russo: Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology. 2000, 56 (3):
Google Scholar